Skip to main content

A Turn Back to “Poison Pills” in Response to the Coronavirus Pandemic?

Client memorandum | March 23, 2020

With stock prices having declined precipitously in the midst of the coronavirus pandemic, many companies are turning their attention to whether their corporate governance structures enable them to protect their long-term shareholders from those who may seek to exploit the current situation by amassing a significant position in the company, at an extraordinarily low price, with the objective of pursuing goals that may not be in the long-tern best interests of the company and its shareholders. Of note, in just the past several days, four large companies have adopted shareholder rights plans (so-called “poison pills”) to protect against unauthorized accumulations of their stock. A total of ten companies have adopted rights plans in the last few weeks. Some of the plans have unusual features. In the attached memorandum, we discuss whether more companies are likely to adopt rights plans; and we offer related practice points for the current environment.

Additional information

icon View File

This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.